Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-05-14
1976-06-08
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, 424 92, C12K 104, G01N 3102, G01N 3316
Patent
active
039624137
ABSTRACT:
This invention relates to the use of Brucella ovis antigens to diagnose the presence of Brucella canis in an animal. B. canis is the causative agent of canine brucellosis. Further, this invention relates to a plate test where B. ovis antigens are employed for rapid accurate determination of B. canis.
REFERENCES:
jones, J. Bacti, vol. 95, Feb. 1968, pp. 625-630.
Meyer, Am J. Vet. Res., vol. 30, Oct. 1969, pp. 1751-1756.
Alton, WHO, Monograph Ser. 55, 1967, pp. 43-52, 59-64.
Diaz, J. of Bacti, vol. 95, Feb. 1968, pp. 618-624.
The Vet. Bull., vol. 39, 1969, Abs. No. 4094.
The Vet. Bull., vol. 42, 1972, Abs. No. 4450; 6756.
Kelser, Manual of Vet. Bacti, Williams & Wilkins, Balti, 5th ed., 1948, pp. 663-668.
Carmichael Leland E.
George Lisle W.
Cornell Research Foundation Inc.
Fagelson A. P.
Goldberg Jerome D.
LandOfFree
Plate methods for diagnosing Brucella canis infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plate methods for diagnosing Brucella canis infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plate methods for diagnosing Brucella canis infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1100313